T. Rowe Price Mid Cap Equity Research ETF

T. Rowe Price Mid Cap Equity Research ETF

TMID
T. Rowe Price Mid Cap Equity Research ETFUS flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
T. Rowe Price Mid-Cap Equity Research ETF (TMID) is an actively managed exchange-traded fund sponsored by T. Rowe Price Group, Inc., designed to pursue long-term capital growth through a core U.S. mid-cap equity strategy. Launched in 2026 and headquartered in Baltimore, Maryland, the fund is managed by T. Rowe Price Associates, Inc. and is part of the firm’s broader active ETF platform and Structured Research Strategies lineup. The ETF invests primarily in equity securities of U.S. mid-cap companies and seeks to construct a diversified, sector- and industry-neutral portfolio relative to the Russell Midcap Index, using fundamental research and active stock selection based on the firm’s equity research analysts’ best ideas. TMID typically holds more than 300 stocks and carries an expense ratio of 0.47%. T. Rowe Price is a global investment management firm serving individual and institutional investors, retirement plans, and financial intermediaries across public markets and other investment strategies; within ETFs, it offers active funds spanning equity, fixed income, multi-asset, digital assets, and thematic strategies. TMID expands the firm’s structured research platform, which also includes the T. Rowe Price U.S. Equity Research ETF and the T. Rowe Price Emerging Markets Equity Research ETF. The most recent major company change is the launch of three fully transparent active equity ETFs on September 17, 2026, including TMID, alongside the T. Rowe Price Biotech ETF and T. Rowe Price Small-Cap ETF, all of which began trading on Nasdaq. This launch broadened T. Rowe Price’s active ETF lineup and reflected a continued strategic expansion of its ETF franchise.